Schering-Plough
SGP
#545
Rank
$46.19 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : $8.17 Billion USD

According to Schering-Plough's latest financial reports the company's total debt is $8.17 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31$8.17 B
2006-12-31$2.65 B-27.77%
2005-12-31$3.67 B-7.17%
2004-12-31$3.96 B15.38%
2003-12-31$3.43 B-20.4%
2002-12-31$4.31 B127%
2001-12-31$1.90 B-27.76%
2000-12-31$2.63 B
1998-12-31$2.05 B-16.42%
1997-12-31$2.45 B120.95%
1996-12-31$1.11 B